NicOx submits naproxcinod NDA

NicOx S.A. (Euronext:COX) submitted an NDA to FDA for naproxcinod to treat the signs and symptoms of osteoarthritis. The company plans to submit an MAA to EMEA next quarter. Naproxcinod is a cyclooxyg...